BURZIK CATHERINE M has filed 5 insider transactions across 2 companies since January 2019.
Most recent transaction: a grant/award of 930 shares of BECTON DICKINSON & CO ($BDX) on January 28, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 28, 2025 | BECTON DICKINSON & CO | $BDX | BURZIK CATHERINE M | Director | A | Common Stock | 930 | $0.00 | 14,264.0000 | 290,389,000 | 6.97% | 0.00% |
| April 8, 2024 | Orthofix Medical Inc. | $OFIX | BURZIK CATHERINE M | Not found | F | Common Stock | 47486 | $14.23 | 112,803.0000 | 36,729,258 | 29.63% | 0.13% |
| Jan. 23, 2024 | BECTON DICKINSON & CO | $BDX | BURZIK CATHERINE M | Director | A | Common Stock | 900 | $0.00 | 13,242.0000 | 288,392,000 | 7.29% | 0.00% |
| Jan. 22, 2019 | BECTON DICKINSON & CO | $BDX | BURZIK CATHERINE M | Director | A | Common Stock | 923 | $0.00 | 8,324.0000 | 0 | 12.47% | 0.00% |
| Jan. 24, 2023 | BECTON DICKINSON & CO | $BDX | BURZIK CATHERINE M | Director | A | Common Stock | 848 | $0.00 | 13,425.0000 | 0 | 6.74% | 0.00% |